21ьз╕ C

Borussia Dortmund GmbH & Co. KGaA: annual press conference - preliminary results fiscal year 2025/2026

News Provided by PR Newswire2026-08-21

Borussia Dortmund GmbH & Co. KGaA: annual press conference - preliminary results fiscal year 2025/2026

[21-August-2026]

DORTMUND, Germany, Aug. 21, 2026 /PRNewswire/ -- The annual press conference of Borussia Dortmund GmbH & Co. KGaA regarding the preliminary results for the financial year 2025/2026 will take place in Dortmund today on 11:30 CET. The conference can be followed real-time via LIVE-Stream hosted at http://www.bvb.de/tv as well as at our IR website http://aktie.bvb.de.

Dortmund, August 21^st, 2026

Borussia Dortmund GmbH & Co. KGaA
Borussia Dortmund Geschäftsführungs-GmbH

Contact:
Dr. Robin Steden
Inhouse Counsel / Investor Relations

View original content:https://www.prnewswire.com/news-releases/borussia-dortmund-gmbh--co-kgaa-annual-press-conference--preliminary-results-fiscal-year-20252026-302857221.html

SOURCE Borussia Dortmund GmbH & Co. KGaA

Company Codes: ISIN:DE0005493092,XETRA:BVB.DE

2026

The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.

/assets/img/cw-stocks.png

/assets/img/crweworld-podcast.jpg

Charter plane crash kills 8 near remote radar site in western Alaska, U.S. military says

Charter plane crash kills 8 near remote radar site in western Alaska, U.S. military says

Singapore Institute of Technology and IBM Aim to Establish Quantum-Safe Centre that Addresses Post-Quantum Risks and Advances Singapore's Quantum-Safe Resilience

Singapore Institute of Technology and IBM Aim to Establish Quantum-Safe Centre that Addresses Post-Quantum Risks and Advances Singapore's Quantum-Safe Resilience

Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) NDA Accepted by NMPA, Poised to Become World's First Approved 4-1BB-Targeting Therapy

Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) NDA Accepted by NMPA, Poised to Become World's First Approved 4-1BB-Targeting Therapy

Announcement from The Extra General Meeting of Hacksaw AB

Announcement from The Extra General Meeting of Hacksaw AB

Industrial Development Bureau of Hengqin Officially Joins ICCA, Exploring Global Resource Channels for the Macao-Hengqin MICE Industry

Industrial Development Bureau of Hengqin Officially Joins ICCA, Exploring Global Resource Channels for the Macao-Hengqin MICE Industry

ZoomInfo Technologies Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GTM

ZoomInfo Technologies Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GTM

GTM Investors Have Opportunity to Lead ZoomInfo Technologies Inc. Securities Fraud Lawsuit with SBS Law

GTM Investors Have Opportunity to Lead ZoomInfo Technologies Inc. Securities Fraud Lawsuit with SBS Law

Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REGN

Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REGN

Nasdaq Advertisement

Post on CRWE World

U.S. National Debt Clock

ad1

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

ad2

Our content delivery solution through CRWE WORLD, CRWE Press Release and CRWE Tube gives corporations and businesses a vehicle to expand their exposure

CLICK HERE FOR MORE INFORMATION

ad3

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

ad4

Share your videos. Upload your videos for free on CRWETube

www.CRWETube.com

ad5

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

CRWE WORLD Advertising Services Rate Join CRWE WORLD Affiliate Program $('nav ul li a').on('click', function () { var $this = $(this); var target = $this.text().toLowerCase(); $this.parent().addClass('selected').siblings().removeClass('selected'); $('#' + target).fadeIn('slow').removeClass('hide').siblings().not('nav').not('.nav-info-behind').hide(); return false; }); });